The following are the major categories of questions the Drug Information Center typically answers along with the type of information required before a response is formulated:
Adverse Drug Reactions
Suspected adverse drug reactions are accessed.
Specific information regarding predisposing factors, relationship to dose or duration of therapy, incidence, clinical manifestations, and management will be provided.
Compounding
Research and provide compounding formulations that are not pharmaceutically available for special patient needs
Design of Dosage Regimens
Provide information regarding dosing pediatric patients, geriatric patients and other patients with special dosing requirements.
Drug Administration
Information regarding drug administration techniques, preferred routes of administration, and monitoring parameters for assessing efficacy and toxicity of drug administration.
Drug Therapy of Choice
Current and alternative therapy recommendations based on literature analysis and patient data are provided.
Evaluation of Drug Reactions
The significance of drug-drug, drug-food, drug-disease or drug laboratory test interaction is evaluated.
Intravenous Compatibility
Provide information regarding intravenous compatibility in various routes and formulations.
Pregnancy and Lactation
Provide comprehensive drug information regarding compatibility and safety and therapy alternatives during pregnancy and breast-feeding.
Product Availability
Provide information on drug shortages and drug recalls; when possible, provide formulary alternatives.
Product and Foreign Drug Identification
Identify domestic, foreign, and investigational drugs; if available provide product composition and US equivalent.
